Mahabbat NA,Khan TA,Elyas MF,Mahabbat AA,Oraif AM .2024 .Role of in-vitro fertilization (IVF) in unexplained infertility management: A systematic review. Cureus, 10(10) : .
Jiang VS,Bormann CL .2023 .Arti cial intelligence in the in vitro fertilization laboratory: A review of advancements over the last decade. Fertil Steril, 05(1) : 17-23.
Eller ABP,Ejzenberg D,Monteleone PAA,Soares JM .2023 .Vitamin D and in-vitro fertilization: A systematic review. J Assist Reprod Genet, 10(4) : 735-43.
Kaleli S,Kervancioglu ME,Erol N,Alakbarova U,Aksahin E,Ocer IF .2023 .Evaluating the e cacy of ovulation stimulation with intrauterine insemination in women with diminished ovarian reserve compared to women with normal ovarian reserve. Int J Gynecol Obst, 10(2) : 620-7.
Hosseinzadeh P,Wild RA,Hansen KR .2023 .Diminished ovarian reserve: Risk for preeclampsia in in-vitro fertilization pregnancies. Fertil Steril, 03(5) : 802-3.
Wang ZY,Huang SX,Yang JD,Li DP,Xu YW .2023 .Subfertile Chinese patients with diminished ovarian reserve: An analysis of pregnancy outcomes of ART cycles. Pak J Med Sci, 10(2) : 338-43.
Zhu Q,Li Y,Ma J,Ma H,Liang X .2023 .Potential factors result in diminished ovarian reserve: A comprehensive review. J Ovarian Res, 10(1) : 208.
Li S,Hu L,Zhang C. .2021 .E ect of chronological age of patients with diminished ovarian reserve onin-vitro fertilization outcome. J Obstet Gynaecol, 1922996(4) : 654-7.
Dakhly DM,Bassiouny YA,Bayoumi YA,Hassan MA,Gouda HM,Hassan AA .2018 .The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in-vitro fertilization: randomized control trial. Eur J Obstet Gynecol Reprod Biol, 06 : 161-5.
Bassiouny YA,Dakhly DMR,Bayoumi YA,Hashish NM .2015 .Does the addition of growth hormone to the in-vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril, 11(3) : 697-702.
Lattes K,Brassesco M,Gomez M,Checa MA . .Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in-vitro fertilisa-. , : .
Eftekhar M,A atoonian A,Mohammadian F,Eftekhar T. .2013 .Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet, 10(5) : 1017-21.
.2023 .. J Reprod Infertil, 10(4) : 279-86.
. .. , : 14155.
Kyrou D,Kolibianakis EM,Venetis CA,Papanikolaou EG,Bontis J,Tarlatzis BC .2007 .How to improve the probability of pregnancy in poor responders undergoing in-vitro fertilization: A systematic review and meta-analysis. Fertil Steril, 12(3) : 749-66.
Ho YK,Lee TH,Lee CI,Cheng EH,Huang CC,Huang LS,Kucuk T,Kozinoglu H,Kaba A .2017 .Growth hormone co-treatcontrolled ovarian stimulation in infertile women of ment within a GnRH agonist long protocol in patients with advanced age, poor responders, and previous in-vitro fertil- poor ovarian response: A prospective, randomized, clinical ization failure patients. Taiwan J Obstet Gynecol2017; trial. J Assist Reprod Genet, 10(6) : 806-10.
Hart RJ,Rombauts L,Norman RJ .2017 .Growth hormone in IVF cycles: Any hope. Curr Opin Obstet Gynecol, 10(3) : 119-25.
Mohammadshirazi Z,Alyasin A,Hosseini MA,Hazari V.,Ipsa E,Cruzat VF,Kagize JN,Yovich JL,Keane KN .2019 .Growth hormone and insulin-like growth factor action in reproductive tissues. Front Endocrinol (Lausanne), 00777 : 777.